Study elucidates how anti-amyloid antibody therapy lecanemab works in Alzheimer’s disease
Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer’s disease that clears toxic amyloid plaques and delays cognitive decline.